Lantern Pharma Inc.
NASDAQ:LTRN

Watchlist Manager

Lantern Pharma Inc.

NASDAQ:LTRN

Watchlist

Dividends

Price: 3.8 USD 1.6% Market Closed

Market Cap: 41m USD

Have any thoughts about
Lantern Pharma Inc.?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 3.8 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

LTRN Alert

Lantern Pharma Inc.

3.8

+0.06 (+1.6%)

52 Week Range	2.94 10.65
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Lantern Pharma Inc.

What unique competitive advantages
does Lantern Pharma Inc. hold over its rivals?

What risks and challenges
does Lantern Pharma Inc. face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Lantern Pharma Inc..

What unique competitive advantages
does Lantern Pharma Inc. hold over its rivals?

What risks and challenges
does Lantern Pharma Inc. face in the near future?

Has there been any significant insider trading activity
in Lantern Pharma Inc. recently?

Summarize the latest earnings call
of Lantern Pharma Inc..

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Lantern Pharma Inc..

Provide P/S
for Lantern Pharma Inc..

Provide P/E
for Lantern Pharma Inc..

Provide P/OCF
for Lantern Pharma Inc..

Provide P/FCFE
for Lantern Pharma Inc..

Provide P/B
for Lantern Pharma Inc..

Provide EV/S
for Lantern Pharma Inc..

Provide EV/GP
for Lantern Pharma Inc..

Provide EV/EBITDA
for Lantern Pharma Inc..

Provide EV/EBIT
for Lantern Pharma Inc..

Provide EV/OCF
for Lantern Pharma Inc..

Provide EV/FCFF
for Lantern Pharma Inc..

Provide EV/IC
for Lantern Pharma Inc..

Show me price targets
for Lantern Pharma Inc. made by professional analysts.

What are the Revenue projections
for Lantern Pharma Inc.?

How accurate were the past Revenue estimates
for Lantern Pharma Inc.?

What are the Net Income projections
for Lantern Pharma Inc.?

How accurate were the past Net Income estimates
for Lantern Pharma Inc.?

What are the EPS projections
for Lantern Pharma Inc.?

How accurate were the past EPS estimates
for Lantern Pharma Inc.?

What are the EBIT projections
for Lantern Pharma Inc.?

How accurate were the past EBIT estimates
for Lantern Pharma Inc.?

Compare the revenue forecasts
for Lantern Pharma Inc. with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Lantern Pharma Inc. and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Lantern Pharma Inc. against its competitors.

Analyze the profit margins
(gross, operating, and net) of Lantern Pharma Inc. compared to its peers.

Compare the P/E ratios
of Lantern Pharma Inc. against its peers.

Discuss the investment returns and shareholder value creation
comparing Lantern Pharma Inc. with its peers.

Analyze the financial leverage
of Lantern Pharma Inc. compared to its main competitors.

Show all profitability ratios
for Lantern Pharma Inc..

Provide ROE
for Lantern Pharma Inc..

Provide ROA
for Lantern Pharma Inc..

Provide ROIC
for Lantern Pharma Inc..

Provide ROCE
for Lantern Pharma Inc..

Provide Gross Margin
for Lantern Pharma Inc..

Provide Operating Margin
for Lantern Pharma Inc..

Provide Net Margin
for Lantern Pharma Inc..

Provide FCF Margin
for Lantern Pharma Inc..

Show all solvency ratios
for Lantern Pharma Inc..

Provide D/E Ratio
for Lantern Pharma Inc..

Provide D/A Ratio
for Lantern Pharma Inc..

Provide Interest Coverage Ratio
for Lantern Pharma Inc..

Provide Altman Z-Score Ratio
for Lantern Pharma Inc..

Provide Quick Ratio
for Lantern Pharma Inc..

Provide Current Ratio
for Lantern Pharma Inc..

Provide Cash Ratio
for Lantern Pharma Inc..

What is the historical Revenue growth
over the last 5 years for Lantern Pharma Inc.?

What is the historical Net Income growth
over the last 5 years for Lantern Pharma Inc.?

What is the current Free Cash Flow
of Lantern Pharma Inc.?

Discuss the annual earnings per share (EPS)
trend over the past five years for Lantern Pharma Inc..

Wall Street Price Targets Revenue Forecast Operating Income Forecast Net Income Forecast See Also

Section:

Wall Street Price Targets

Revenue Forecast

Operating Income Forecast

Net Income Forecast

Wall Street
Price Targets

LTRN Price Targets Summary
Lantern Pharma Inc.

Wall Street analysts forecast LTRN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LTRN is 22.44 USD with a low forecast of 18.18 USD and a high forecast of 27.3 USD.

LTRN Average Forecast

Wall Street Target

22.44 USD

491% Upside

LTRN Highest Forecast

Wall Street Target

27.3 USD

618% Upside

Lowest

Price Target

18.18 USD

378% Upside

Average

Price Target

22.44 USD

491% Upside

Highest

Price Target

27.3 USD

618% Upside

Lantern Pharma Inc. Competitors:
Price Targets

TSHA

Taysha Gene Therapies Inc

291% Upside

INMB

INmune Bio Inc

200% Upside

CCCC

C4 Therapeutics Inc

704% Upside

000403

Pacific Shuanglin Bio pharmacy Co Ltd

42% Upside

TSHA

Taysha Gene Therapies Inc

291% Upside

INMB

INmune Bio Inc

200% Upside

CCCC

C4 Therapeutics Inc

704% Upside

000403

Pacific Shuanglin Bio pharmacy Co Ltd

42% Upside

ANAB

AnaptysBio Inc

126% Upside

BIIB

Biogen Inc

45% Upside

ORGO

Organogenesis Holdings Inc

12% Upside

QURE

Uniqure NV

163% Upside

Revenue
Forecast

Revenue Estimate
Lantern Pharma Inc.

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Lantern Pharma Inc.

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-6%

Average Miss

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Lantern Pharma Inc.

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-10%

Average Miss

What are analyst estimates?

What is LTRN's stock price target?

Price Target
22.44 USD

According to Wall Street analysts, the average 1-year price target for LTRN is 22.44 USD with a low forecast of 18.18 USD and a high forecast of 27.3 USD.

	Eledon Pharmaceuticals Inc NASDAQ:ELDN	3.65 USD 1.39%
	Lantern Pharma Inc. NASDAQ:LTRN	3.8 USD 1.6%
	Porch Group Inc NASDAQ:PRCH	5.94 USD 6.45%
	Beacon Roofing Supply Inc NASDAQ:BECN	118.34 USD 0.31%
	Taysha Gene Therapies Inc NASDAQ:TSHA	1.72 USD
	D Market Elektronik Hizmetler ve Ticaret AS NASDAQ:HEPS	3.23 USD 1.89%

	Franklin Covey Co NYSE:FC	30.6 USD 2.55%
	Mohawk Industries Inc NYSE:MHK	114.3 USD 3.05%
	Ardmore Shipping Corp NYSE:ASC	9.89 USD 0.41%
	ASGN Inc NYSE:ASGN	68.05 USD 1.52%
	Skyworks Solutions Inc NASDAQ:SWKS	69.4 USD 3.29%
	Weatherford International PLC NASDAQ:WFRD	53.11 USD 2.35%

	Johnson & Johnson NYSE:JNJ	162.81 USD -0.11%
	Bank of America Corp NYSE:BAC	40.89 USD 3.08%
	Mastercard Inc NYSE:MA	527.64 USD 1.5%
	Salesforce Inc NYSE:CRM	279.4 USD 2.82%
	Abbvie Inc NYSE:ABBV	211.77 USD 0.1%
	Home Depot Inc NYSE:HD	351.31 USD 1.17%

	Arista Networks Inc NYSE:ANET	83.51 USD 4.21%
	Visa Inc NYSE:V	331.8 USD 0.99%
	Texas Pacific Land Corp NYSE:TPL	1 321.07 USD 5.28%
	KLA Corp NASDAQ:KLAC	713 USD 4.62%
	Manhattan Associates Inc NASDAQ:MANH	172.5 USD 5.5%
	Monolithic Power Systems Inc NASDAQ:MPWR	606.06 USD 6.1%

	ServiceNow Inc NYSE:NOW	844.33 USD 4.03%
	EOG Resources Inc NYSE:EOG	123.92 USD 2.34%
	Monster Beverage Corp NASDAQ:MNST	55.09 USD 1.38%
	Copart Inc NASDAQ:CPRT	52.65 USD 0.67%
	Applied Materials Inc NASDAQ:AMAT	155.66 USD 3.81%
	Airbnb Inc NASDAQ:ABNB	122.86 USD 2.92%

Lantern Pharma Inc.
NASDAQ:LTRN

Wall Street
Price Targets

LTRN Price Targets Summary
Lantern Pharma Inc.

Revenue
Forecast

Revenue Estimate
Lantern Pharma Inc.

Operating Income
Forecast

Operating Income Estimate
Lantern Pharma Inc.

Net Income
Forecast

Net Income Estimate
Lantern Pharma Inc.

See Also

What is LTRN's stock price target?

Price Target
22.44 USD

Company

Help

Tools

Stocks

Lantern Pharma Inc. NASDAQ:LTRN

Wall Street Price Targets

LTRN Price Targets Summary Lantern Pharma Inc.

Revenue Forecast

Revenue Estimate Lantern Pharma Inc.

Operating Income Forecast

Operating Income Estimate Lantern Pharma Inc.

Net Income Forecast

Net Income Estimate Lantern Pharma Inc.

See Also

What is LTRN's stock price target? Price Target 22.44 USD

Company

Help

Tools

Stocks

Lantern Pharma Inc.
NASDAQ:LTRN

Wall Street
Price Targets

LTRN Price Targets Summary
Lantern Pharma Inc.

Revenue
Forecast

Revenue Estimate
Lantern Pharma Inc.

Operating Income
Forecast

Operating Income Estimate
Lantern Pharma Inc.

Net Income
Forecast

Net Income Estimate
Lantern Pharma Inc.

What is LTRN's stock price target?

Price Target
22.44 USD